The effect of S-adenosylmethionine on cognitive performance in mice: An animal model meta-analysis

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Montgomery, Sarah E ^a   Sepehry, Amir A ^b,c   Wangsgaard, John D ^a   Koenig, Jeremy E ^d  

^a MOUNT SAINT VINCENT UNIVERSITY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; S ADENOSYLMETHIONINE; NOOTROPIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL EFFECTIVENESS; COGNITIVE DEFECT; COMPARATIVE STUDY; CONTROLLED STUDY; DIET SUPPLEMENTATION; MENTAL PERFORMANCE; MORRIS WATER MAZE TEST; MOUSE; NONHUMAN; SPATIAL MEMORY; TASK PERFORMANCE; TREATMENT DURATION; Y-MAZE TEST; ALZHEIMER DISEASE; ANIMAL; COGNITION; DIET; DRUG EFFECTS; FOLIC ACID DEFICIENCY; META ANALYSIS;

ANIMALIA; MUS;

ALZHEIMER DISEASE; ANIMALS; COGNITION; DIET; DIETARY SUPPLEMENTS; FOLIC ACID DEFICIENCY; MICE; MODELS, ANIMAL; NOOTROPIC AGENTS; S-ADENOSYLMETHIONINE;

EID: 84908570891     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0107756     Document Type: Article

References (36)

1. Batsch NL, Mittelman MS, Blankman K, Ellenbogen M., Graham N, et al. (2012) World alzheimer report 2012: Overcoming the stigma of dementia.
2. Anonymous (2012) A new way of looking at the impact of dementia in canada.
3. Graham N, Emery T, Hodges J. (2004) Distinctive cognitive profiles in alzheimer's disease and subcortical vascular dementia. Journal of Neurology, Neurosurgery & Psychiatry 75: 61-71.
4. Cavallaro RA, Fuso A, Nicolia V., Scarpa S. (2010) S-adenosylmethionine prevents oxidative stress and modulates glutathione metabolism in TgCRND8 mice fed a B-vitamin deficient diet. J Alzheimer's Dis 20: 997-1002.
5. Fuso A, Nicolia V, Ricceri L., Cavallaro RA, Isopi E, et al. (2012) S-adenosylmethionine reduces the progress of the alzheimer-like features induced by B-vitamin deficiency in mice. Neurobiol Aging 33: 1482.e1-1482.e16.
6. Hooijmans CR, Blom HJ, Oppenraaij-Emmerzaal D, Ritskes-Hoitinga M, Kiliaan AJ. (2009) S-adenosylmethionine and S-adenosylhomocysteine levels in the aging brain of APP/PS1 alzheimer mice. Neurol Sci 30: 439-445.
7. Rudolph ML, Rabinoff M, Kagan BL. (2011) A prospective, open-label, 12 week trial of S-adenosylmethionine in the symptomatic treatment of alzheimer's disease. Neuroscience & Medicine 2: 222-225.
8. Thompson MA, Bauer BA, Loehrer L.L., Cha SS, Mandrekar JN, et al. (2009) Dietary supplement S-adenosyl-L-methionine (AdoMet) effects on plasma homocysteine levels in healthy human subjects: A double-blind, placebo-controlled, randomized clinical trial. Journal of Alternative and Complementary Medicine 15: 523-529
9. Chan A, Rogers E, Shea TB. (2009) Dietary deficiency in folate and vitamin E under conditions of oxidative stress increases phospho-tau levels: Potentiation by ApoE4 and alleviation by S-adenosylmethionine. J Alzheimer's Dis 17: 483-487.
10. Coppedè F. (2010) One-carbon metabolism and alzheimer's disease: Focus on epigenetics. Curr Genomics 11: 246.
11. Chan A, Tchantchou F, Rogers E.J., Shea TB. (2009) Dietary deficiency increases presenilin expression, gamma-secretase activity, and abeta levels: Potentiation by ApoE genotype and alleviation by s-adenosyl methionine. J Neurochem 110: 831-836.
12. Remington R, Chan A, Paskavitz J., Shea TB. (2009) Efficacy of a vitamin/nutriceutical formulation for moderate-stage to later-stage alzheimer's disease: A placebo-controlled pilot study. Am J Alzheimers Dis Other Demen 24: 27-33.
13. Chan A, Tchantchou F, Graves V., Rozen R, Shea T. (2008) Dietary and genetic compromise in folate availability reduces acetylcholine, cognitive performance and increases aggression: Critical role of S-adenosyl methionine. The Journal of Nutrition, Health and Aging 12: 252-261.
14. Shea TB. (2007) Effects of dietary supplementation with N-acetyl cysteine, acetyl-L-carnitine and S-adenosyl methionine on cognitive performance and aggression in normal mice and mice expressing human ApoE4. Neuromolecular medicine 9: 264-269.
15. Tchantchou F, Graves M, Ortiz D., Rogers E, Shea TB. (2004) Dietary supplementation with 3-deaza adenosine, N-acetyl cysteine, and S-adenosyl methionine provide neuroprotection against multiple consequences of vitamin deficiency and oxidative challenge. Neuromol Med 6: 93-103.
16. Huang Y. (2011) Roles of apolipoprotein E4 (ApoE4) in the pathogenesis of alzheimer's disease: Lessons from ApoE mouse models. . Biochem Soc Trans 39: 924.
17. Herrmann M, Tami A, Wildemann B., Wolny M, Wagner A, et al. (2009) Hyperhomocysteinemia induces a tissue specific accumulation of homocysteine in bone by collagen binding and adversely affects bone. Bone 44: 467-475.
18. Veeranna V, Zalawadiya SK, Niraj A, Pradhan J., Ference B, et al. (2011) Homocysteine and reclassification of cardiovascular disease risk. J Am Coll Cardiol 58: 1025-1033.
19. Ordovás JM, Smith CE. (2010) Epigenetics and cardiovascular disease. Nature Reviews Cardiology 7: 510-519.
20. Stewart S, Cacucci F, Lever C. (2011) Which memory task for my mouse? A systematic review of spatial memory performance in the tg2576 alzheimer's mouse model. J Alzheimer's Dis 26: 105-126.
21. Moher D, Liberati A, Tetzlaff J., Altman DG. (2009) Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Ann Intern Med 151: 264-269.
22. Hooijmans C, de Vries R, Leenaars M, Ritskes-Hoitinga M. (2011) The gold standard publication checklist (GSPC) for improved design, reporting and scientific quality of animal studies GSPC versus ARRIVE guidelines. Lab Anim 45: 61-61.
23. Borenstein M, Hedges LV, Higgins J.P., Rothstein HR. (2011) Comprehensive meta analysis. 2.0.
24. Hedges LV, Olkin I, Statistiker M., Olkin I, Olkin I. (1985) Statistical methods for meta-analysis.: Academic Press New York.
25. Higgins JP, Thompson SG, Deeks J.J., Altman DG. (2003) Measuring inconsistency in meta-analyses. BMJ: British Medical Journal 327: 557.
26. DerSimonian R, Laird N. (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188.
27. Tchantchou F, Graves M, Ortiz D., Rogers E, Shea TB. (2004) Dietary supplementation with 3-deaza adenosine, N-acetyl cysteine, and S-adenosyl methionine provide neuroprotection against multiple consequences of vitamin deficiency and oxidative challenge. Neuromolecular medicine 6: 93-103.
28. Kilkenny C, Browne W, Cuthill I.C., Emerson M., Altman DG. (2010) Animal research: Reporting in vivo experiments: The ARRIVE guidelines. Br J Pharmacol 160: 1577-1579.
29. Perel P, Roberts I, Sena E., Wheble P, Briscoe C, et al. (2007) Comparison of treatment effects between animal experiments and clinical trials: Systematic review. BMJ 334: 197.
30. Chan A, Remington R, Kotyla E., Lepore A, Zemianek J, et al. (2010) A vitamin/nutriceutical formulation improves memory and cognitive performance in community-dwelling adults without dementia. The Journal of Nutrition Health and Aging 14: 224-230.
31. Bottiglieri T, Godfrey P, Flynn T., Carney M, Toone B, et al. (1990) Cerebrospinal fluid S-adenosylmethionine in depression and dementia: Effects of treatment with parenteral and oral S-adenosylmethionine. Journal of Neurology, Neurosurgery & Psychiatry 53: 1096-1098.
32. Enquobahrie DA, Feldman HA, Hoelscher D.H., Steffen LM, Webber LS, et al. (2012) Serum homocysteine and folate concentrations among a US cohort of adolescents before and after folic acid fortification. Public Health Nutrition 15: 1818.
33. Shuaibi AM, House JD, Sevenhuysen GP. (2008) Folate status of young canadian women after folic acid fortification of grain products. J Am Diet Assoc 108: 2090-2094.
34. Sener U, Zorlu Y, Karaguzel O., Ozdamar O, Coker I, et al. (2006) Effects of common anti-epileptic drug monotherapy on serum levels of homocysteine, vitamin B12, folic acid and vitamin B6. Seizure 15: 79-85.
35. Wani NA, Hamid A, Kaur J. (2008) Folate status in various pathophysiological conditions. IUBMB Life 60: 834-842.
36. Andrès E, Loukili NH, Noel E, Kaltenbach G., Abdelgheni MB, et al. (2004) Vitamin B12 (cobalamin) deficiency in elderly patients. Can Med Assoc J 171: 251-259.